Byrne Asset Management LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 2 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Byrne Asset Management LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$84,000
+83900.0%
3,270
-6.6%
0.07%
+6.2%
Q2 2023$100
-1.0%
3,500
-16.7%
0.06%
-9.7%
Q1 2023$101
-99.9%
4,200
-35.5%
0.07%
-10.0%
Q4 2022$110,494
+64.9%
6,515
+44.1%
0.08%
+53.8%
Q3 2022$67,000
-9.5%
4,520
+8.9%
0.05%
-5.5%
Q2 2022$74,000
-31.5%
4,150
+3.8%
0.06%
-17.9%
Q1 2022$108,000
-5.3%
4,000
+29.4%
0.07%
-9.5%
Q4 2021$114,0003,0900.07%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders